tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
TipRanksTop Financial ExpertsInsidersLuke Miels

Luke Miels Insider Profile

4 Followers
Luke Miels, Executive Vice-President at AstraZeneca, holds ― shares in GlaxoSmithKline (Ticker: GB:GSK), holds ― shares in AstraZeneca (Ticker: GB:AZN).
See the Hottest Stocks Based on Insider Trading >
tipranks
Luke Miels

Luke Miels
AstraZeneca (AZN)
Executive Vice-President

Ranked #68,157 out of 98,042 Corporate Insiders

Profitable Transactions

45%
5 out of 11 Profitable Transactions

Average Return

-7.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

Luke Miels does not currently own shares as a corporate insider.
A breakdown of Luke Miels's holdings
See the Top Stocks by Insiders

Insider Roles

AstraZeneca
(AZN)
Executive Vice-President
GlaxoSmithKline
(GSK)
Divisional President
Roles that Luke Miels holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
GlaxoSmithKline
(GSK)
Rating:Informative Sell
Date:Feb 20, 2020 - Feb 20, 2021
Return:+22.20%
The most profitable trade made by Luke Miels
See the Latest Stocks Traded by Insiders

Luke Miels's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
AZN
AstraZeneca
May 23, 2016
Executive Vice-President
Uninformative Buy
―
―
GSK
GlaxoSmithKline
Jul 18, 2024
Divisional President
Uninformative Buy
118.77K
―
List of latest transactions for each holding click on a transaction to see Luke Miels's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Luke Miels insider profile FAQ

What is the percentage of profitable transactions made by Luke Miels?
The percentage of profitable transactions made by Luke Miels is 45%.
    What is the average return per transaction made by Luke Miels?
    The average return per transaction made by Luke Miels is -7.40%.
      What stocks does Luke Miels hold?
      Luke Miels holds: GB:AZN, GB:GSK stocks.
        What was Luke Miels’s latest transaction?
        Luke Miels latest transaction was an Uninformative Buy of 118.77K.
          What was Luke Miels's most profitable transaction?
          Luke Miels’s most profitable transaction was an Informative Sell of GB:GSK stock on February 20, 2020. The return on the trade was 22.20%.
            What is Luke Miels's role in AstraZeneca?
            Luke Miels's role in AstraZeneca is Executive Vice-President.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.